Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2
Xueyi Liang(Sun Yat-sen University), Juan Xia(University of Electronic Science and Technology of China), Bin Cheng(Columbia University Irving Medical Center), Jian Xu(University of Southern California), Xianyue Ren(Sun Yat-sen University), Fan Ping(Tongji University), Xiaoan Tao(Sun Yat-sen University), Yun Wang(Zhejiang Gongshang University), Hongfei Wang(University of California, Santa Barbara), Chi Zhang(Sun Yat-sen University), Zhaona Fan(Sun Yat-sen University), Tong Wu(Guangzhou University of Chinese Medicine), Miao Deng(Sichuan University)
Cited by 26
Related Papers
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
|Biomedicine & Pharmacotherapy|2019|200
Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
|Cancer Medicine|2019|197
Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells
|Genes & Development|2009|178
Current Understanding of IL-37 in Human Health and Disease
|Frontiers in Immunology|2021|178